Breaking News
Get 60% Off 0
Cyber Monday Deal: Up to 60% off InvestingPro
CLAIM SALE
Close

Dr. Lal PathLabs Ltd (DLPA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
3,019.40 +16.50    +0.55%
13:30:40 - Real-time Data. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE600L01024 
S/N:  LALPATHLAB
  • Volume: 55,102
  • Bid/Ask: 3,019.40 / 3,019.65
  • Day's Range: 2,984.10 - 3,028.00
Dr. Lal PathLabs 3,019.40 +16.50 +0.55%

NS:DLPA Financials

 
Gain a comprehensive overview of Dr. Lal PathLabs financials. Assess key figures from the balance sheet and income statement. Explore essential metrics such as total assets, total liabilities, equity, revenue, and net income to understand the company’s overall financial performance.

Dr. Lal PathLabs Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter, the company reported sales was INR 6,602 million compared to INR 6,013 million a year ago. Revenue was INR 6,821 million compared to INR 6,194 million a year ago. Net income was INR 1,292 million compared to INR 1,093 million a year ago. Basic earnings per share from continuing operations was INR 15.52 compared to INR 13.16 a year ago. Diluted earnings per share from continuing operations was INR 15.48 compared to INR 13.12 a year ago. For the six months, sales was INR 12,621 million compared to INR 11,423 million a year ago. Revenue was INR 13,046 million compared to INR 11,748 million a year ago. Net income was INR 2,356 million compared to INR 1,919 million a year ago. Basic earnings per share from continuing operations was INR 28.3 compared to INR 23.11 a year ago. Diluted earnings per share from continuing operations was INR 26.24 compared to INR 23.05 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

DLPA Income Statement

Gross margin TTM 57.84%
Operating margin TTM 22.06%
Net Profit margin TTM 17.11%
Return on Investment TTM 17.42%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 6602 6019 5454.41 5389
Gross Profit 4089 3659 2594.3 3229
Operating Income 1672 1353 1105.48 1046
Net Income 1292 1064 845.35 813

DLPA Balance Sheet

Quick Ratio MRQ 2.63
Current Ratio MRQ 2.87
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 9.92%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 25975 24559.63
Total Liabilities 5623 5705.99
Total Equity 20352 18853.64

DLPA Cash Flow Statement

Cash Flow/Share TTM 64.4
Revenue/Share TTM 281.65
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DLPA Comments

Write your thoughts about Dr. Lal PathLabs Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rammit malik
Rammit malik May 24, 2024 19:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very high chances of doing wonders to fly high in june month, something big is on cards
Bipin singh
Bipin singh Feb 18, 2024 9:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
something is happening in Dr lal path labs may be it can break 2600 on Tuesday
anandhan Murugesan
anandhan Murugesan Oct 04, 2023 14:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy buy
Jigar Joshi
Jigar Joshi Jun 17, 2023 15:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Monday ye stock 2135 ke upar jayega investment kar lena dosto
Saurav Valecha
Saurav Valecha Jun 17, 2023 15:13
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how you came to know that..??
Vivek Sharma
Vivek Sharma Jan 13, 2023 14:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sell sell
pravin chauhan
pravin chauhan Oct 16, 2022 17:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bye bye bye bye____________ bye bye bye___________2700 only 5 day
pravin chauhan
pravin chauhan Oct 16, 2022 17:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bye bye bye bye____________ bye bye bye___________2700 only 5 day
Durgesh Telang
Durgesh Telang Jan 29, 2022 23:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When are the Q3 results ?
Kartik Shah
Kartik Shah Dec 31, 2021 12:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it will touch 4200 very shortly
sai mere
sai mere Dec 24, 2019 18:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
BUY BUY BUY BUY ____________ Dr Lal PathLabs Ltd (DLPA) ___________________ BUY BUY BUY
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email